CAPLIN POINT LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,290 INR | -0.12% |
|
-0.98% | -4.91% |
| May. 24 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
| May. 16 | Caplin Point Laboratories to Seek Acquisitions | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.17B | - | - | ||||
| 41.97B | ||||||
| 22.34B | ||||||
| 15.25B | ||||||
| 14B | ||||||
| 12.06B |
